Skip to Content
PgCert | Postgraduate Taught

Biopharmaceutical Engineering

Entry year
Academic Year 2025/26
Entry requirements
2.2
Attendance
1 year (Part-time)
Places available
80 (Part Time)

Biopharmaceutical products are highly important in today’s global healthcare systems in treating illnesses and disease. The industry in the British Isles has seen significant investment, particularly in the Republic of Ireland (RoI) where there has been capital investment of approximately £7.97 billion in new facilities, mostly in the last 10 years. The global market for biopharmaceuticals was valued at £149 billion in 2017, and is projected to reach £419 billion by 2025, growing at an annual rate of 13.8% from 2018 to 2025. As a result, over 30,000 highly skilled people are currently employed in Ireland north and south with new companies setting up facilities in RoI every year. The increased uptake of skilled biopharmaceutical employees has necessitated the need for a high quality education in this sector.
Queen’s University Belfast School of Chemistry and Chemical Engineering has a proven track record for delivering high quality teaching and research and has launched the options-based Postgraduate Certificate in Biopharmaceutical Engineering from this platform. This qualification will provide students with knowledge and skills which will help them to find employment in the field of biopharmaceutical production, separation and purification by applying fundamental science and engineering principles.
It is partly designed to augment skills and qualifications already gained by STEM graduates and by staff who are working in the Biopharmaceutical Engineering sector but who wish to add some specialisations in order to progress. It should also anyone seeking a career pathway change who meets he entrance criteria.
Through studying this postgraduate course students will be able to gain a highly relevant qualification which will give them greatly enhanced employability.
Through the use of theory and mathematical approaches to engineering problems, students will understand and become skilled in the development of systems which can facilitate biopharmaceuticals production and their subsequent purification.
This course is run in collaboration with our industrial partner Eli Lilly, a global company with excellent standing in the field of pharmaceutical and biopharmaceutical production and commercialisation. A collaborative course of this nature is the first of its kind in the British Isles and will provide students with real-world knowledge of how these systems are operated in an industrial setting through the case studies and first-hand knowledge imparted by the academics and industry staff delivering the course.

Q.U.B. School of Chemistry and Chemical Engineering is ranked joint 1st in the UK for research intensity and ranked 13th in the UK for studying Chemistry (Complete Universities Guide UK 2023)

Biopharmaceutical Engineering highlights

Internationally Renowned Experts

You will be taught by experts in the field of medicinal chemistry, chemical engineering, separation science and industry experts who work in Eli Lilly. Having this level of expertise will greatly enhance your understanding and experience of the course.

World Class Facilities

There will be an opportunity for you to see on-site demonstrations of the School’s state-of-the-art pharmaceutical analysis suite. This will allow you to see and experience hands-on separation science as it applies to the pharmaceutical and biopharmaceutical industries. Some work may also be undertaken on our new Solid State NMR.

Industry Links

This course is run in collaboration with the (bio)pharmaceutical company Eli Lilly, whose staff deliver one of the optional modules. This will grant you direct access to the knowledge and experience of individuals who work in the biopharmaceutical industry.